Is Wegovy Prescribed for Weight Loss?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Wegovy is prescribed specifically for weight loss in eligible patients. The medication contains semaglutide, which works by slowing stomach emptying and signaling fullness to the brain. Approximately 35% of U.S. adults meet clinical criteria for obesity, yet access to branded GLP-1 therapy remains limited by cost and insurance coverage.

How Semaglutide Promotes Weight Loss

Semaglutide activates GLP-1 receptors throughout the digestive system and central nervous system. This activation triggers reduced appetite, increases feelings of satiety, and slows the rate at which food moves from your stomach into the small intestine. The combination of these effects naturally leads to lower calorie intake without requiring severe dietary restriction.

Clinical trials demonstrate that patients using semaglutide lose approximately 15% of body weight over 68 weeks with lifestyle modifications. Some individuals achieve weight reductions exceeding 20% when combining medication with consistent diet and exercise. The medication's effect on appetite regulation addresses the biological mechanisms that make weight loss challenging, rather than relying solely on willpower.

Wegovy vs. Compounded Semaglutide Injections

Wegovy is the branded version of semaglutide manufactured by Novo Nordisk. The medication is FDA-approved and widely recognized, but often costs between $900 and $1,300 per month without insurance coverage. Many insurers require step-therapy protocols or weight-based criteria before approving reimbursement, creating significant delays in treatment access.

PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan. Compounded medications contain identical active ingredients to their branded counterparts, following rigorous quality standards. PlexusDx medications are available to patients in all 50 states without requiring insurance approval, HSA and FSA accounts are eligible, and pricing remains consistent regardless of your dose level.

Clinical Criteria for Semaglutide Prescription

Semaglutide is prescribed to adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, hypertension, or sleep apnea. Healthcare providers evaluate medical history, current medications, and metabolic health before recommending treatment. The medication is not appropriate for individuals with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

PlexusDx conducts thorough health screening during the consultation process to ensure semaglutide is a suitable choice for your specific situation. This personalized approach helps identify which GLP-1 therapy—whether semaglutide injection, oral semaglutide, or tirzepatide compounds—aligns best with your health profile and weight loss goals.

Genetic Insights for Personalized GLP-1 Response

Individual responses to GLP-1 medications vary significantly based on genetic factors affecting appetite regulation and metabolic pathways. PlexusDx offers the Precision Peptide Genetic Test, which identifies key genetic variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants influence how your body responds to semaglutide and related compounds.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between Wegovy and semaglutide?

Wegovy is the brand name for semaglutide manufactured by Novo Nordisk and approved by the FDA for weight loss. Both branded Wegovy and compounded semaglutide contain the same active ingredient and work identically in your body. The primary differences are price, insurance coverage requirements, and availability—PlexusDx compounded semaglutide is more accessible and affordable for most patients.

How much weight do people lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I get semaglutide through PlexusDx without insurance?

Yes. PlexusDx requires no insurance, no membership fees, and serves all 50 states. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with flat pricing—your dose may increase, but your price won't. HSA and FSA accounts are eligible for payment.

Are there side effects with semaglutide for weight loss?

Common side effects include nausea, vomiting, constipation, and diarrhea, typically mild and temporary as your body adjusts. Most patients experience reduced side effects after 2-4 weeks of consistent dosing. Serious side effects are rare but may include pancreatitis or gallbladder complications; PlexusDx providers screen for risk factors during initial consultation.

How does the Precision Peptide Genetic Test help with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.